| 276 | 16 | 45 |
| 下载次数 | 被引频次 | 阅读次数 |
目的评价早期目标导向治疗(EGDT)对脓毒症或脓毒性休克患者的疗效。方法计算机检索美国国立医学图书馆MEDLINE数据库,Cochrane临床试验数据库、Embase、PubMed、SpringerLink、Elsevier-ScienceDirect、OVID-lww-oup等英文数据库及中国生物医学文献数据库、中国期刊全文数据库、重庆维普数据库、中国知网期刊全文库、万方数据库、移动数字图书馆等中文数据库自建库至2017年8月的文献。检索词为:脓毒症、脓毒性休克、液体治疗、早期目标导向治疗、sepsis、severe sepsis、septic shock、early goal-directed therapy。应用RevMan5.2软件进行Meta分析,根据异质性检验结果选择固定效应模型或随机效应模型进行数据合并,计算合并风险比及其95%可信区间并对分析结果进行敏感性分析,采用绘制漏斗图法评估发表偏倚。结果共纳入21项研究,共计6 369例患者,其中行EGDT患者3 167例,常规治疗患者3 202例。所纳入的文献偏倚以Cochrane协作网的偏倚风险评价工具进行评估。经Meta分析,与常规液体治疗相比,EGDT方案对脓毒症或脓毒性休克患者的住院病死率、28d病死率、住院时间及机械通气时间的影响差异有统计学意义,结果分别为(RR=0.77,95%CI=0.600.99,P=0.04);(RR=0.68,95%CI=0.550.86,P<0.05);(MD=-3.24,95%CI=-4.49~-1.99,P<0.05);(MD=-1.09,95%CI=-1.41~-0.77,P<0.05),但对于60d病死率及90d病死率并没有显著影响,结果均显示无统计学意义,结果分别为(RR=0.83,95%CI=0.641.09,P=0.17);(RR=0.99,95%CI=0.901.09,P=0.87)。结论 EGDT方案可降低脓毒症或脓毒性休克患者住院病死率、28d病死率、住院时间及机械通气时间。尚不能证实EGDT可改善脓毒症或脓毒性休克患者的60d及90d病死率。
Abstract：Objective To evaluate the efficacy of early goal-directed therapy(EGDT)in patients with sepsis or septic shock.Methods By searching the English and Chinese literature databases from inception to August 2017,and setting up the key words with sepsis,severe sepsis,septic shock,fluid therapy,early goaldirected therapy,a meta analysis was conducted with RevMan5.2 software.According to the results of heterogeneity test,fixed effect model or random effect model for data merging were selected,consolidated risk ratio and 95% confidence interval were calculated,and sensitivity of the results was analyzed after using funnel plot method to assess the publication bias.Results A total of 21 studies involving 6 369 patients were included,in which 3 167 patients were treated with EGDT,and 3 202 patients were treated with conventional fluid management.The bias of included literature was assessed using the Cochrane collaboration bias risk assessment tool.By meta analysis,a significant reduction was observed in hospital mortality,28 days mortality,length of hospital stay and mechanical ventilation time associated with EGDT compared with the conventional fluid therapy.The results were:RR =0.77,95%CI:0.600.99,P =0.04;RR =0.68,95%CI:0.550.86,P <0.05;MD =-3.24,95%CI:-4.49~-1.99,P <0.05;MD =-1.09,95%CI:-1.41~-0.77,P <0.05 respectively.However,no differences were found on 60 days mortality and 90 days mortality(RR =0.83,95%CI:0.641.09,P =0.17;RR =0.99,95%CI:0.90~ 1.09,P =0.87).Conclusion EGDT can reduce the hospital mortality,28 days mortality,length of hospital stay and mechanical ventilation time in patients with sepsis or septic shock.It is not proved that EGDT can improve the mortality of patients with sepsis and septic shock at 60 and 90 days.
[1]韦文林.脓毒症的治疗的进展[J].医学信息,2015,28(21):360.
[2]李新宇.严重脓毒症液体复苏治疗策略[J].内科急危重症杂志,2012,18(3):141-144.
[3]RIVERS E,NGUYEN B,HAVSTAD S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345(19):1368-1377.
[4]GAIESKI D F,MIKKELSEN M E,BAND R A,et al.Impact of time to anti-biotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department[J].Crit Care Med,2010,38(4):1045-1053.
[5]Early Goal-Directed Therapy Collaborative Group of Zhejiang Province.The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock:a multi-center,prospective,randomized,controlled study[J].Critical medical emergency medicine in China,2010,22(6):331-334.
[6]蔡国龙,童洪杰,郝雪景,等.早期目标导向治疗对严重脓毒症/脓毒性休克患者病死率的影响:系统文献回顾与Meta分析[J].中华危重病急救医学,2015,27(6):439-442.
[7]张医虎.早期目标导向治疗对严重脓毒症疗效的Meta分析[D].天津:天津医科大学,2015.
[8]CHEN X,ZHU W,JING T,et al.Early outcome of earlygoal directed therapy for patients with sepsis or septic shock:a systematic review and meta-analysis of randomized controlled trials[J].Oncotarget,2017,8(16):27510-27519.
[9]The ARISE Investigators.A randomized trial of protocol-based care for earl septic shock[J].N Engl J Med,2014,370(18):1683-1693.
[10]The ARISE Investigators,ANZICS Clinical Trials Group.Goal-directed resuscitation for patients with early septic shock[J].N Engl J Med,2014,371(16):1496-1506.
[11]KELM D J,PERRIN J T,CARTIN-CEBA R,et al.Fluid overload in patient with severe sepsis and septic shock treated with early-goal directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death[J].Shock,2015,43(1):68-73.
[12]BONE R,BALK R,CERRA F,et al.American College of chest physicians/society of critical care medicine consensus conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,20(6):864-874.
[13]ANDREWS B,MUCHEMWA L,KELLY P,et al.Simplified severe sepsis protocol:a randomized controlled trial of modified early goal-directed therapy in Zambia[J].Crit Care Med,2014,42(11):2315-2324.
[14]PEAKE S L,DELANEY A,BAILEY M,et al.Goal-directed resuscitation for patients with early septic shock[J].N Engl J Med,2014,371(16)1496-1506.
[15]吴新军,孙小勇,何立东,等.早期目标导向治疗感染性休克的临床分析[J].现代实用医学,2016,28(12):1654-1655.
[16]LIN S M,HUANG C D,LIN H C,et al.A modified goaldirected protocol improves clinical outcomes in intensive care unit patients with septic shock:a randomized controlled trial[J].Shock,2006,28(6):551-557.
[17]MOUNCEY P R,OSBORN T M,POWER G S,et al.Trial of Early,Goal-Directed Resuscitation for Septic Shock[J].N Engl J Med,2015,373(6):1301-1311.
[18]YEALY D M,KELLUM J A,HUANG D T,et al.A randomized trial of protocol-based care for early septic shock[J].N Engl J Med,2014,370(18):1683-1693.
[19]高宇,张军建,邹世斌.早期目标导向治疗糖尿病合并脓毒性休克48例临床观察[J].吉林医学,2015,36(1):17-19.
[20]王忠华.早期目标导向治疗严重脓毒症休克30例临床分析[J].吉林医学,2014,35(18):3992.
[21]吴先龙.严重脓毒症早期应用集束化治疗的依从性及对病死率的影响[J].中国呼吸与危重监护杂志,2013,12(1):92-93.
[22]金宝灿,广跃乾,刘厚鹏,等.早期目标导向治疗严重脓毒性休克40例临床观察[J].现代预防医学,2012,39(15):4042-4043,4046.
[23]李轶男,周立新,温伟标,等.集束化治疗对严重脓毒症患者预后的前瞻性随机对照研究[J].海南医学,2012,27(7):7-10.
[24]TUCHSCHMIDT J,FRIED J,ASTIZ M,et al.Elevation of cardiac output and oxygen delivery improves outcome in septic shock[J].Chest,1992,102(1):216-220.
[25]YU M,LEVY M M,SMITH P,et al.Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients:aprospective,randomized,controlled study[J].Crit Care Med,1993,21(6):830-838.
[26]HAYES M A,TIMMINS A C,YAU E H,et al.Elevation of systemic oxygen delivery in the treatment of critically ill patients[J].N Engl J Med,1994,330(24):1717-1722.
[27]AlíA I,ESTEBEN A,GORDO F,et al.A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock[J].Chest,1999,115(2):453-461.
[28]时玲燕.严重感染和感染性休克早期集束化治疗临床分析[J].中国继续医学教育,2017,9(12):121-122.
[29]黄康全.早期集束化治疗感染性休克的临床效果探究[J].首都食品与医药,2017,24(2):36-37.
[30]陆肖娴.早期集束化治疗在感染性休克中应用的临床观察[J].中外医学研究,2010,9(20):8-10.
[31]HIGGINS J P T,AlTMAN D G,STERNE J A C.Assessing Risk of Bias in Included Studies[M].America:John Wiley&Sons,Ltd,2011:187-241.
[32]王丹,翟俊霞,牟振云,等.Meta分析中的异质性及其处理方法[J].中国循证医学杂志,2009,9(10):1115-1118.
基本信息:
中图分类号:R459.7
引用信息:
[1]张静静,赵红玉,陈杰,等.早期目标导向治疗对脓毒症或脓毒性休克疗效的Meta分析[J].新疆医科大学学报,2018,41(05):625-633.
基金信息:
新疆维吾尔自治区自然科学基金医学联合基金(2016D01C338)
2017-11-04
2017
2018-03-01
2018
1
2018-05-15
2018-05-15